Gene · 5670
Papers3,544
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,544
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Colorectal cancer and gut microbiota studies in China. | Gut Microbes | 2023 | 37482657 | PubTator, text mining | PubMed |
| A five-collagen-based risk model in lung adenocarcinoma: prognostic significance and immune landscape. | Front Oncol | 2023 | 37476379 | PubTator, text mining | PubMed |
| The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer. | J Cancer Res Clin Oncol | 2023 | 37460806 | PubTator, text mining | PubMed |
| The protective and pathogenic role of Th17 cell plasticity and function in the tumor microenvironment. | Front Immunol | 2023 | 37457739 | PubTator, text mining | PubMed |
| Capitalizing glycomic changes for improved biomarker-based cancer diagnostics. | Explor Target Antitumor Ther | 2023 | 37455827 | PubTator, text mining | PubMed |
| Emerging Biosensing Methods to Monitor Lung Cancer Biomarkers in Biological Samples: A Comprehensive Review. | Cancers (Basel) | 2023 | 37444523 | PubTator, text mining | PubMed |
| Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies. | Cancers (Basel) | 2023 | 37444422 | PubTator, text mining | PubMed |
| Phage Interactions with the Nervous System in Health and Disease. | Cells | 2023 | 37443756 | PubTator, text mining | PubMed |
Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE. | Br J Surg | 2023 | 37442562 | PubTator, text mining | PubMed |
| Fibulin1 and mesothelin expressions in pancreas ductal adenocarcinoma. | North Clin Istanb | 2023 | 37435286 | PubTator, text mining | PubMed |
Deoxythymidylate kinase (DTYMK) participates in cell cycle arrest to promote pancreatic adenocarcinoma progression regulated by miR-491-5p through TP53 and is associated with tumor immune infiltration. | J Gastrointest Oncol | 2023 | 37435228 | PubTator, text mining | PubMed |
| Hepatocellular Neoplasm of Uncertain Potential of Malignancy or Well-Differentiated Hepatocellular Carcinoma Arising within Hepatocellular Adenoma. | Case Rep Surg | 2023 | 37427296 | PubTator, text mining | PubMed |
| Mixed squamous and clear cell ovarian adenocarcinoma arising from endometriosis in a 71 year old patient. | Gynecol Oncol Rep | 2023 | 37415960 | PubTator, text mining | PubMed |
| Predicted Proteome Association Studies of Breast, Prostate, Ovarian, and Endometrial Cancers Implicate Plasma Protein Regulation in Cancer Susceptibility. | Cancer Epidemiol Biomarkers Prev | 2023 | 37409955 | PubTator, text mining | PubMed |
| A rare cause of intestinal obstruction in children: signet-ring cell adenocarcinoma of the colon. | Ulus Travma Acil Cerrahi Derg | 2023 | 37409928 | PubTator, text mining | PubMed |
| KL-6 levels in the connective tissue disease population: typical values and potential confounders-a retrospective, real-world study. | Front Immunol | 2023 | 37409133 | PubTator, text mining | PubMed |
| Current Strategies for Exosome Cargo Loading and Targeting Delivery. | Cells | 2023 | 37408250 | PubTator, text mining | PubMed |
| Single-cell analysis reveals transcriptomic and epigenomic impacts on the maternal-fetal interface following SARS-CoV-2 infection. | Nat Cell Biol | 2023 | 37400500 | PubTator, text mining | PubMed |
| Clinical Advances and Perspectives in Targeted Radionuclide Therapy. | Pharmaceutics | 2023 | 37376181 | PubTator, text mining | PubMed |
A Case of Prostatic Signet-Ring Cell-like Carcinoma with Pagetoid Spread and Intraductal Carcinoma and Long-Term Survival: PD-L1 and Mismatch Repair System Proteins (MMR) Immunohistochemical Evaluation with Systematic Literature Review. | J Pers Med | 2023 | 37374005 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5670/papers?page=16